Global Trastuzumab Biosimilar Market Research Report 2021

1 Trastuzumab Biosimilar Market Overview

• 1.1 Product Overview and Scope of Trastuzumab Biosimilar
• 1.2 Trastuzumab Biosimilar Segment by Type
  • 1.2.1 Global Trastuzumab Biosimilar Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Adjuvant Breast Cancer
  • 1.2.3 Metastatic Breast Cancer
  • 1.2.4 Metastatic Gastric Cancer
  • 1.2.5 Others
• 1.3 Trastuzumab Biosimilar Segment by Application
  • 1.3.1 Trastuzumab Biosimilar Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospital Pharmacy
  • 1.3.3 Online Pharmacy
• 1.4 Global Trastuzumab Biosimilar Market Size Estimates and Forecasts
  • 1.4.1 Global Trastuzumab Biosimilar Revenue 2016-2027
  • 1.4.2 Global Trastuzumab Biosimilar Sales 2016-2027
  • 1.4.3 Trastuzumab Biosimilar Market Size by Region: 2016 Versus 2021 Versus 2027

2 Trastuzumab Biosimilar Market Competition by Manufacturers

• 2.1 Global Trastuzumab Biosimilar Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Trastuzumab Biosimilar Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Trastuzumab Biosimilar Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Trastuzumab Biosimilar Manufacturing Sites, Area Served, Product Type
• 2.5 Trastuzumab Biosimilar Market Competitive Situation and Trends
  • 2.5.1 Trastuzumab Biosimilar Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Trastuzumab Biosimilar Players Market Share by Revenue
  • 2.5.3 Global Trastuzumab Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Trastuzumab Biosimilar Retrospective Market Scenario by Region

• 3.1 Global Trastuzumab Biosimilar Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Trastuzumab Biosimilar Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Trastuzumab Biosimilar Market Facts & Figures by Country
  • 3.3.1 North America Trastuzumab Biosimilar Sales by Country
  • 3.3.2 North America Trastuzumab Biosimilar Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Trastuzumab Biosimilar Market Facts & Figures by Country
  • 3.4.1 Europe Trastuzumab Biosimilar Sales by Country
  • 3.4.2 Europe Trastuzumab Biosimilar Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Trastuzumab Biosimilar Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Trastuzumab Biosimilar Sales by Region
  • 3.5.2 Asia Pacific Trastuzumab Biosimilar Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Trastuzumab Biosimilar Market Facts & Figures by Country
  • 3.6.1 Latin America Trastuzumab Biosimilar Sales by Country
  • 3.6.2 Latin America Trastuzumab Biosimilar Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Trastuzumab Biosimilar Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Trastuzumab Biosimilar Sales by Country
  • 3.7.2 Middle East and Africa Trastuzumab Biosimilar Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Trastuzumab Biosimilar Historic Market Analysis by Type

• 4.1 Global Trastuzumab Biosimilar Sales Market Share by Type (2016-2021)
• 4.2 Global Trastuzumab Biosimilar Revenue Market Share by Type (2016-2021)
• 4.3 Global Trastuzumab Biosimilar Price by Type (2016-2021)

5 Global Trastuzumab Biosimilar Historic Market Analysis by Application

• 5.1 Global Trastuzumab Biosimilar Sales Market Share by Application (2016-2021)
• 5.2 Global Trastuzumab Biosimilar Revenue Market Share by Application (2016-2021)
• 5.3 Global Trastuzumab Biosimilar Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Amgen Inc.
  • 6.1.1 Amgen Inc. Corporation Information
  • 6.1.2 Amgen Inc. Description and Business Overview
  • 6.1.3 Amgen Inc. Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Amgen Inc. Product Portfolio
  • 6.1.5 Amgen Inc. Recent Developments/Updates
• 6.2 Pfizer Inc
  • 6.2.1 Pfizer Inc Corporation Information
  • 6.2.2 Pfizer Inc Description and Business Overview
  • 6.2.3 Pfizer Inc Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Pfizer Inc Product Portfolio
  • 6.2.5 Pfizer Inc Recent Developments/Updates
• 6.3 Samsung Bioepis
  • 6.3.1 Samsung Bioepis Corporation Information
  • 6.3.2 Samsung Bioepis Description and Business Overview
  • 6.3.3 Samsung Bioepis Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Samsung Bioepis Product Portfolio
  • 6.3.5 Samsung Bioepis Recent Developments/Updates
• 6.4 Merck & Co.
  • 6.4.1 Merck & Co. Corporation Information
  • 6.4.2 Merck & Co. Description and Business Overview
  • 6.4.3 Merck & Co. Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Merck & Co. Product Portfolio
  • 6.4.5 Merck & Co. Recent Developments/Updates
• 6.5 Biocon Limited
  • 6.5.1 Biocon Limited Corporation Information
  • 6.5.2 Biocon Limited Description and Business Overview
  • 6.5.3 Biocon Limited Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Biocon Limited Product Portfolio
  • 6.5.5 Biocon Limited Recent Developments/Updates
• 6.6 Teva Pharmaceutical
  • 6.6.1 Teva Pharmaceutical Corporation Information
  • 6.6.2 Teva Pharmaceutical Description and Business Overview
  • 6.6.3 Teva Pharmaceutical Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Teva Pharmaceutical Product Portfolio
  • 6.6.5 Teva Pharmaceutical Recent Developments/Updates
• 6.7 Genentech
  • 6.6.1 Genentech Corporation Information
  • 6.6.2 Genentech Description and Business Overview
  • 6.6.3 Genentech Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Genentech Product Portfolio
  • 6.7.5 Genentech Recent Developments/Updates
• 6.8 Mundipharma
  • 6.8.1 Mundipharma Corporation Information
  • 6.8.2 Mundipharma Description and Business Overview
  • 6.8.3 Mundipharma Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Mundipharma Product Portfolio
  • 6.8.5 Mundipharma Recent Developments/Updates
• 6.9 Celltrion
  • 6.9.1 Celltrion Corporation Information
  • 6.9.2 Celltrion Description and Business Overview
  • 6.9.3 Celltrion Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Celltrion Product Portfolio
  • 6.9.5 Celltrion Recent Developments/Updates
• 6.10 Henlius
  • 6.10.1 Henlius Corporation Information
  • 6.10.2 Henlius Description and Business Overview
  • 6.10.3 Henlius Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Henlius Product Portfolio
  • 6.10.5 Henlius Recent Developments/Updates

7 Trastuzumab Biosimilar Manufacturing Cost Analysis

• 7.1 Trastuzumab Biosimilar Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Trastuzumab Biosimilar
• 7.4 Trastuzumab Biosimilar Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Trastuzumab Biosimilar Distributors List
• 8.3 Trastuzumab Biosimilar Customers

9 Trastuzumab Biosimilar Market Dynamics

• 9.1 Trastuzumab Biosimilar Industry Trends
• 9.2 Trastuzumab Biosimilar Growth Drivers
• 9.3 Trastuzumab Biosimilar Market Challenges
• 9.4 Trastuzumab Biosimilar Market Restraints

10 Global Market Forecast

• 10.1 Trastuzumab Biosimilar Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Trastuzumab Biosimilar by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Trastuzumab Biosimilar by Type (2022-2027)
• 10.2 Trastuzumab Biosimilar Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Trastuzumab Biosimilar by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Trastuzumab Biosimilar by Application (2022-2027)
• 10.3 Trastuzumab Biosimilar Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Trastuzumab Biosimilar by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Trastuzumab Biosimilar by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List